Tohru Yamada
- Biotechnology top 0.5%
- Cancer Research and Treatments 25
- Microbiology top 2%
- Oncology top 5%
- Cancer-related Molecular Pathways 10
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 6
- Ecology top 5%
-
- Intracranial Aneurysms: Treatment and Complications 11
- Vascular Malformations Diagnosis and Treatment 6
-
- Nanoplatforms for cancer theranostics 10
-
- Cerebrovascular and Carotid Artery Diseases 5
- Co-authors
- Tapas K. Das GuptaTeruaki MukaiyamaCraig W. BeattieAnanda M. ChakrabartyKonstantin ChristovKazuhide KimbaraLaura BratescuVasu Punj
- Cited by
- BiotechnologyMicrobiologyOncology
- Journals
- Neurologia medico-chirurgica (7 papers)Cell Cycle (4 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Tohru Yamada
80 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 114
- Biotechnology 813
- Microbiology 210
- Oncology 523
- Molecular Biology 1.2k
- Ecology 443
Countries citing papers authored by Tohru Yamada
This map shows the geographic impact of Tohru Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tohru Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tohru Yamada more than expected).
Fields of papers citing papers by Tohru Yamada
This network shows the impact of papers produced by Tohru Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tohru Yamada. The network helps show where Tohru Yamada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tohru Yamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 60 | |
| 4 | 2023 | 22 | |
| 5 | 2022 | 6 | |
| 6 | 2016 | 68 | |
| 7 | 2016 | 117 | |
| 8 | 2013 | 146 | |
| 9 | 2010 | 7 | |
| 10 | Mechanism of the selective penetration of azurin derived peptides into cancer cells | 2007 | 3 |
| 11 | 2007 | 6 | |
| 12 | A cupredoxin derived peptide inhibits angiogenesis and mammary end bud transformation in vitro. | 2006 | 2 |
| 13 | 2006 | 6 | |
| 14 | 2006 | 24 | |
| 15 | 2005 | 90 | |
| 16 | Alterations of T lymphocyte populations in Parkinson’s disease. | 2004 | 5 |
| 17 | 1992 | 5 | |
| 18 | Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues. | 1990 | 58 |
| 19 | 1990 | 1 | |
| 20 | 1990 | 75 |
About Tohru Yamada
Tohru Yamada is a scholar working on Biotechnology, Neurology and Rheumatology, having authored 85 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Research and Treatments (25 papers), Intracranial Aneurysms: Treatment and Complications (11 papers), Cancer-related Molecular Pathways (10 papers), Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (6 papers), Vascular Malformations Diagnosis and Treatment (6 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). The work is most often cited by research in Biotechnology (813 citations), Microbiology (210 citations) and Oncology (523 citations). Tohru Yamada has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Tapas K. Das Gupta, Teruaki Mukaiyama, Craig W. Beattie, Ananda M. Chakrabarty, Konstantin Christov, Kazuhide Kimbara, Laura Bratescu, Vasu Punj, Anne Shilkaitis and Dibyen Majumdar. Their work appears in journals such as Neurologia medico-chirurgica, Cell Cycle, Proceedings of the National Academy of Sciences, Cancer Research and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.